Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics: Introduction (0:00) Prologue: Saturday Night Fever (1:35) Baby Boomers' Guide to Mechanisms of Action (3:07) Second-Line Treatment (12:36) Complications Associated with Bispecific Antibodies (23:41) Case Presentations (25:52) New Bispecific T-Cell Engagers — Surovatamig (26:24) Other Novel Agents (50:05) CME information and select publications (https://researchtopractice.com/BispecificsFL2026)
Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46) Bispecific Antibodies — Dr Lonial (19:16) Antibody-Drug Conjugates — Dr Richardson (37:08) Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10) CME information and select publications (https://researchtopractice.com/activity/integrating-new-advances-into-community-oncology-practice-6/)
Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics: Introduction: ESMO 2026; Recent FDA Approvals (0:00) Selection of Endocrine Therapy — Dr Antonarakis (2:24) Utility of PARP Inhibitors — Dr Agarwal (22:59) AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42) Radiopharmaceuticals — Dr Agarwal (45:02) CME information and select publications (https://researchtopractice.com/activity/integrating-new-advances-into-community-oncology-practice-7/)
Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics: Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00) ER-Positive Breast Cancer (5:01) HER2-Positive Breast Cancer (1:19:08) Triple-Negative Breast Cancer (1:48:54) CME information and select publications (https://researchtopractice.com/activity/integrating-new-advances-into-community-oncology-practice-8/)
Featuring an interview with Dr Matthew Lunning, including the following topics: Bispecific antibody/antibody-drug conjugate combinations (0:00) A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07) CME information and select publications (https://researchtopractice.com/ASCO2026/NHL/Micro/2)
Featuring a presentation by Dr Matthew Matasar, including the following topics: Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00) Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41) Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01) Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47) Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34) Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31) Discussion of Questions from the Community (50:20) CME information and select publications (https://researchtopractice.com/GR2026/DLBCL)